Eric Thomas Schmidt

Eric Thomas Schmidt has an estimated net worth of $3.34 Million. This is based on reported shares across multiple companies, which include Allogene Therapeutics, Inc., Revolution Medicines, Inc., and RELMADA THERAPEUTICS, INC..

2021 was Eric Thomas Schmidt's most active year for acquiring shares with 7 total transactions. Eric Thomas Schmidt's most active month to acquire stocks was the month of February. 2020 was Eric Thomas Schmidt's most active year for disposing of shares, totalling 4 transactions. Eric Thomas Schmidt's most active month to dispose stocks was the month of February. 2021 saw Eric Thomas Schmidt paying a total of $271,423.34 for 307,169 shares, this is the most they've acquired in one year. In 2021 Eric Thomas Schmidt cashed out on 22,950 shares for a total of $307,888.74, their largest year based on trade value.